ConductScience.org, home

Gene · 3003

NIH grants2,103

NIH grants whose papers are about the gene, through NIH's grant-paper links.

1,721 to 1,740 of 2,103

Download this page as JSON
GrantTitleGZMK papersNewest fiscal year
G12MD007591RCMI Center for Interdiscplinary Health Research CIHR12016
K08AI102945Self and dietary lipid antigens for invariant natural killer T cells12016
K22CA188163DEFINING THE REGULATORY, NON-CODING, MUTATIONAL LANDSCAPE OF BREAST CANCER12016
K99HL123638Molecular Programming of Immunological Memory in Human Natural Killer Cells12016
P01CA066726Immuno/Immuno-Gene Therapies for Thoracic Malignancies12016
P01CA081534Chronic Lymphocytic Leukemia Research Consortium12016
P01CA095426Innate Immunity: Elucidation and Modulation for Cancer Therapy12016
P20MD002285CNTR OF EXCELLENCE FOR PROSTATE CANCER RESEARCH EDUCATION AND COMM SERVICE12016
P50CA130810Translational Research in GI Cancer12016
R01AA020504Effect of Prazosin on Alcohol Craving, Stress Dysregulation and Alcohol Relapse12016
R01AI034495In vivo Prevention of Murine GVHD12016
R01AI042528Cytotoxic T-Cell Responses to HSV in HIV-Infected Persons12016
R01AI048090Recognition of Mtb-infected cells by CD8+ T lymphocytes12016
R01AI057020HIV-Specific T Cell Responses in Rectal Mucosa12016
R01AI065361Vpu inhibits NK cell function through down regulation of NTB-A12016
R01AI070101Mechanisms of hepatitis C virus persistence12016
R01AI094019Genomic systems approach to measure HSV-1-specific T-cell dominance in humans12016
R01AI102893Molecular mechanisms of signaling co-ordination in innate lymphocytes12016
R01CA112567Stromal activation in the progression of high ErbB2/1433zeta DCIS to IBC12016
R01CA155693Decoding NanogP8 in Tumorigenesis12016

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3003/grants?page=87